RxSight Q1 Adj. EPS $(0.19) Beats $(0.28) Estimate, Sales $30.893M Beat $29.744M Estimate

Benzinga Newsdesk www.benzinga.com Positive 81.5%

Neg 0% Neu 0% Pos 81.5%

Comments

No comments yet. Be the first!